Published in Drug Metab Dispos on January 27, 1978
Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93
Akt participation in the Wnt signaling pathway through Dishevelled. J Biol Chem (2001) 2.31
Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem (2000) 2.24
EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science (1990) 1.76
Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci (1991) 1.20
Keratinocyte growth factor. Cell Biol Int (1995) 1.20
Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem (1996) 1.13
Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometry. J Pharm Pharmacol (1973) 1.10
Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J Biol Chem (2001) 1.10
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem (1997) 1.09
Influence of oxygen and pH on plating efficiency and colony development of WI-38 and Vero cells. Exp Cell Res (1974) 1.06
Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann N Y Acad Sci (1991) 1.01
Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. Oncogene (1988) 1.01
Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol. Cell Mol Neurobiol (1997) 1.01
Stat6 and Jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts. J Biol Chem (1996) 1.00
Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett (1992) 1.00
Efficacy of a porcelain refinishing system in restoring surface finish after grinding with fine and extra-fine diamond burs. J Prosthet Dent (1992) 1.00
Fluorescent light-induced chromosome damage in human IMR-90 fibroblasts. Role of hydrogen peroxide and related free radicals. Mutat Res (1980) 1.00
Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation. J Invest Dermatol (1996) 0.99
Growth factor-regulated pathways in epithelial cell proliferation. Am Rev Respir Dis (1990) 0.98
Synthesis of N-propargylphenelzine and analogues as neuroprotective agents. Bioorg Med Chem Lett (2001) 0.97
Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli. Biochem J (1997) 0.96
Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives. Xenobiotica (1999) 0.94
Oxygen and light effects on chromosomal aberrations in mouse cells in vitro. Exp Cell Res (1977) 0.93
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Studies on a serum substitute for mammalian cells in culture. 2. Analyses of fractionated peptone dialysate and the use of glycine peptides. In Vitro (1974) 0.92
In vitro stimulation of rat liver cells by homologous partial hepatectomy serum. In Vitro (1972) 0.92
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Density-dependent effects of oxygen on the growth of mammalian fibroblasts in culture. J Cell Physiol (1978) 0.90
Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res (1998) 0.89
Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants. Neurosci Biobehav Rev (1998) 0.88
Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates. Pharm Res (1988) 0.87
Structure and stereochemistry of some 1,2-disubstituted mitosenes from solvolysis of mitomycin C and mitomycin A. J Med Chem (1975) 0.87
Refinishing of porcelain by using a refinishing kit. J Prosthet Dent (1991) 0.87
Comparison of chemical components and antioxidants capacity of different Echinacea species. J Pharm Pharmacol (2001) 0.86
Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J Chromatogr (1992) 0.85
Bilateral thecomata in ovaries with normal ultrasonographic and radiological appearances, presenting with postmenopausal hirsutism and virilism. J Obstet Gynaecol (2003) 0.85
Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection. J Chromatogr B Biomed Sci Appl (2000) 0.84
Differential expression of the keratinocyte growth factor (KGF) and KGF receptor genes in human vascular smooth muscle cells and arteries. J Cell Physiol (1997) 0.84
A Rho-specific exchange factor Ect2 is induced from S to M phases in regenerating mouse liver. Hepatology (2000) 0.84
Effect of visible light on benzo(a)pyrene binding to DNA of cultured human skin epithelial cells. Cancer Res (1981) 0.84
Effect of intensity and wavelength of fluorescent light on chromosome damage in cultured mouse cells. Photochem Photobiol (1979) 0.84
Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol (2000) 0.83
Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol (1999) 0.83
Herpesvirus salmonis: Characterization of a New Pathogen of Rainbow Trout. J Virol (1978) 0.83
Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine. J Chromatogr (1986) 0.83
Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry (1991) 0.83
Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity. Pediatrics (1987) 0.82
Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.82
The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology (Berl) (1996) 0.82
Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). J Affect Disord (1991) 0.82
Interactions of iprindole with fenfluramine metabolism in rat brain and liver. J Psychiatry Neurosci (1991) 0.82
Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Dev Pharmacol Ther (1988) 0.80
Urinary excretion of phenolic metabolites of N-(n-propyl)amphetamine in man. Res Commun Chem Pathol Pharmacol (1977) 0.80
Metabolism in vitro of N-methylamphetamine with rat liver homogenates. Biochem Pharmacol (1977) 0.80
Chemical and pharmacological evaluation of Hypericum perforatum extracts. Acta Pharmacol Sin (2000) 0.80
Effect of impression tray design and impression technique upon the accuracy of stone casts produced from a putty-wash polyvinyl siloxane impression material. J Dent (1991) 0.80
Trypsin sensitivity of mammallian cells grown in a serum-free medium. In Vitro (1972) 0.80
Evaluation of nuclear-substituted styryl ketones and related compounds for antitumor and cytotoxic properties. J Pharm Sci (1975) 0.79
In vitro metabolism of 1-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenates. J Pharm Pharmacol (1976) 0.79
Pathways in which growth factors and oncogenes interact in epithelial cell mitogenic signal transduction. Ann N Y Acad Sci (1989) 0.79
Determination of p-trifluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure. J Chromatogr B Biomed Sci Appl (1997) 0.79
Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol (1986) 0.79
Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. J Pharm Sci (1992) 0.79
N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain. Pharm Res (1987) 0.79
In vivo phenolic metabolites of N-alkylamphetamines in the rat. Evidence in favor of catechol formation. Drug Metab Dispos (1976) 0.79
"Feeding the baby"--serum and other supplements to chemically defined medium. J Natl Cancer Inst (1974) 0.79
Fungal metabolism of (-)-deprenyl and pargyline. Life Sci (1981) 0.79
Acetylation and pentafluorobenzoylation of lidocaine metabolites in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom (1987) 0.79
Biological efficacy of several commercially available peptones for mammalian cells in culture. Exp Cell Res (1972) 0.78
Recent studies on the MAO inhibitor phenelzine and its possible metabolites. J Neural Transm Suppl (1990) 0.78
Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br J Pharmacol (1987) 0.78
Repair of DNA-protein cross-links in an excision repair-deficient human cell line and its simian virus 40-transformed derivative. Cancer Res (1984) 0.78
N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.78
Electron-capture gas chromatographic analysis of beta-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization. J Chromatogr (1986) 0.78
A serum substitute for mammalian cells in culture. I. Biological efficacy of whole and fractionated peptone dialysate. Proc Soc Exp Biol Med (1972) 0.78
Synthesis and pharmacological evaluation of some , -disubstituted analogs of acetylcholine. J Med Chem (1972) 0.78
Metabolic acetylation of phenelzine in rats. Res Commun Chem Pathol Pharmacol (1988) 0.78
Studies on nucleotide analogs. I. Synthesis of two 9-alpha-D-mannofuranosyladenine phosphates, and their inhibition of adenylate kinase. Carbohydr Res (1973) 0.78
Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine. J Affect Disord (2000) 0.78
Thin-layer chromatographic detection of ivermectin in cattle dung. J Chromatogr B Biomed Sci Appl (1997) 0.77
Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs. J Pharm Sci (1997) 0.77
Metabolism of N,N-diethyl-meta-toluamide by rat liver microsomes. Drug Metab Dispos (1986) 0.77
N,N-dipropargyl-2-phenylethylamine, a potential prodrug of 2-phenylethylamine: neurochemical and neuropharmacological studies in rat. Brain Res Bull (1987) 0.77
Modulation of epithelial cell proliferation in culture by dissolved oxygen. J Cell Physiol (1982) 0.77
Mitomycin antibiotics. Synthesis and activity of 1,2-disubstituted mitosenes. J Med Chem (1977) 0.77
Adverse drug reactions and debrisoquine/sparteine (P450IID6) polymorphism in patients with fibromyalgia. Clin Rheumatol (1997) 0.77
A gas chromatographic procedure for separation and quantitation of the enantiomers of the antidepressant tranylcypromine. Biochem Pharmacol (1992) 0.77
N-(3-chloropropyl)phenylethylamine as a possible prodrug of beta-phenylethylamine: studies in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.77
Long-lasting elevation of alanine in brain produced by the antidepressant phenelzine. Brain Res Bull (1990) 0.77
Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line. Xenobiotica (1993) 0.77
Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatry Neurosci (2000) 0.77
Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity. Dev Pharmacol Ther (1991) 0.77
Rapid analysis of beta-phenylethylamine in tissues and body fluids utilizing pentafluorobenzoylation followed by electron-capture gas chromatography. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.76
Effects of acute and chronic administration of phenelzine on 2-phenylethylamine levels in rat brain. Proc West Pharmacol Soc (1982) 0.76
Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell line. Xenobiotica (2000) 0.76
Human CYP2D6 and metabolism of m-chlorophenylpiperazine. Biol Psychiatry (1998) 0.76
A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detection. Biochem Pharmacol (1981) 0.76
Metabolism of N,N-diethyl-m-toluamide (DEET) by liver microsomes from male and female rats. Simultaneous quantitation of DEET and its metabolites by high performance liquid chromatography. Drug Metab Dispos (1988) 0.76